Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Volume-stable collagen matrix vs graft for multiple gingival recessions

Official title: Volume-Stable Xenogeneic Collagen Matrix Versus Subepithelial Connective Tissue Graft for the Treatment of Multiple Gingival Recessions: A 12-Month Randomized Controlled Clinical Trial

Run by University of Sao Paulo · NCT07613775 · Data updated 2026-11-12

This study tests whether a volume-stable collagen matrix can cover exposed roots as well as a traditional graft, in adults with multiple gingival recessions.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity of Sao Paulo
Academic / other
Locations1 site (Ribeirão Preto, São Paulo)
StatusRecruiting
StartedOctober 19, 2026
Main results expectedOctober 1, 2028
Study endsDecember 1, 2028
Registry record updatedNovember 10, 2026
Trial IDNCT07613775 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18+ with at least two Cairo RT1 gingival recessions in anterior teeth or premolars, 2 mm or greater recession depth, and at least 2 mm keratinized gingiva apical to the recession, seeking root coverage for esthetic or sensitivity reasons.

Probably not a fit

Patients with active periodontal disease, smoking within the past year, or unsuitable mucogingival conditions may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares a volume-stable xenogeneic collagen matrix used with a coronally advanced flap to the standard autogenous subepithelial connective tissue graft with a coronally advanced flap for treating multiple gingival recessions. Participants are adults with at least two Cairo RT1 recessions and 2 mm or more of recession depth, recruited at the University of São Paulo's Ribeirão Preto campus. Primary endpoint is change in gingival recession depth from baseline to 12 months; secondary endpoints include keratinized tissue width, probing depth, clinical attachment level, gingival thickness, root coverage percentage, esthetic outcomes, dentin hypersensitivity, postoperative comfort, and patient satisfaction, assessed via clinical measurements, patient-reported outcomes, photographs, and digital volumetric analysis. The trial aims to determine if the collagen matrix provides comparable root coverage with potentially less donor-site morbidity.

Why it matters

Potential benefit: If successful, patients may achieve similar root coverage with less surgical discomfort by avoiding a palatal connective tissue graft.

How similar studies have gone: Prior approaches using collagen matrices for root coverage have shown promise, but results vary and this head-to-head RCT directly compares with SCTG.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older.
* Presence of at least two Cairo RT1 gingival recessions in anterior teeth and/or premolars.
* Gingival recession depth greater than or equal to 2 mm.
* Presence of at least 2 mm of keratinized gingiva apical to the gingival recession.
* Indication for root coverage treatment due to esthetic concern and/or dentin hypersensitivity.
* Sites with non-carious cervical lesions may be included if they are previously restored and, after restoration, present residual gingival recession greater than or equal to 2 mm.
* Good plaque control, defined as full-mouth plaque score and full-mouth marginal gingival bleeding score below 20%.

Exclusion Criteria:

* Current smokers or individuals who stopped smoking less than 12 months before enrollment.
* Decompensated systemic diseases.
* Pregnancy or lactation.
* Active periodontal disease.
* Untreated root caries.
* Previous mucogingival surgery in the study area.

Where it's running

  • School of Dentistry of Ribeirão Preto, University of Sao Paulo
    Ribeirão Preto, São Paulo, Brazil
    Recruiting

Study contacts

  • Principal investigator: Arthur Belem Novaes Jr, DDS, PhD — University of Sao Paulo
  • Study coordinator: Edgar Daniel Vargas Quiroga, DDS, MSc
  • Email: edgar.vargasquiroga@usp.br
  • Phone: +551633153000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.